31 Lуpez-Muсoz F., Alamo C. Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today. Current Pharmaceutical Design. 2009; 14: 1563–1586.
32 Duman R. S., Aghajanian G. K. Synaptic dysfunction in depression: potential therapeutic targets. Science. 2012; 6103: 68–72.
33 Freud S., Breuer J. Case of Anna O. // Strachey J., Freud A. (eds.). Studies on hysteria. London: Hogarth Press, 1955.
34 Roose S., Cooper A. M., Fonagy P. The scientific basis of psychotherapy // Psychiatry (3rd ed.). Tasman A. et al. (eds.). Chichester, UK: John Wiley and Sons, 2008.
35 Beck A. T. et al. Cognitive therapy of depression. New York: Guilford Press, 1979.
36 Jamison K. R. An unquiet mind: a memoir of moods and madness. New York: Alfred A. Knopf, 1995.
37 Kennedy S. H. et al. Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. American Journal of Psychiatry. 2011; 5: 502–510.
38 Collingwood J. Bipolar disorder genes uncovered. Psych Central. 2016 (https://psychcentral.com/lib/bipolar-disorder-genes-uncovered/).
39 Saks E. R. The center cannot hold: my journey through madness. New York: Hyperion, 2007.
40 Feinberg I. Cortical pruning and the development of schizophrenia. Schizophrenia Bulletin. 1990; 4: 567–568.
41 Glausier J. R., Lewis D. A. Dendritic spine pathology in schizophrenia. Neuroscience. 2013; 251: 90–107.
42 Geschwind D. H., Flint J. Genetics and genomics of psychiatric disease. Science. 2015; 6255: 1489–1494.
43 Clair D. St. et al. Association within a family of a balanced autosomal translocation with major mental illness. Lancet. 1990; 8706: 13–16.
44 Wang Q. et al. The psychiatric disease risk factors DISC1 and TNIK interact to regulate synapse composition and function. Molecular Psychiatry. 2011; 10: 1006–1023.
45 Sekar A. et al. Schizophrenia risk from complex variation of complement component 4. Nature. 2016; 7589: 177–183.
46 Dhindsa R. S., Goldstein D. B. Schizophrenia: from genetics to physiology at last. Nature. 2016; 7589: 162–163.
47 Kellendonk C. et al. Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron. 2006; 4: 603–615.
48 Squire L. S., Wixted J. T. The cognitive neuroscience of human memory since H. M. Annual Review of Neuroscience. 2011; 34: 259–288.
49 Kandel E. R. The molecular biology of memory storage: a dialogue between genes and synapses. Science. 2001; 5544: 1030–1038.
50 Hebb D. O. The organization of behavior: a neuropsychological theory. New York: John Wiley and Sons, 1949.
51 Gustafsson B., Wigstrum H. Physiological mechanisms underlying long-term potentiation. Trends in Neurosciences. 1988; 4: 156–162.
52 Pavlopoulos E. et al. Molecular mechanism for age-related memory loss: the histone-binding protein RbAp48. Science Translational Medicine. 2013; 200: 200ra115.
53 Oury F. et al. Maternal and offspring pools of osteocalcin influence brain development and functions. Cell. 2013; 1: 228–241.
54 Kosmidis S. et al. RbAp48 protein is a critical component of GPR158/ OCN signaling and ameliorates age-related memory loss. Cell Reports. 2018; 25: 959–973.
55 Guerreiro R., Hardy J. Genetics of Alzheimer’s disease. Neurotherapeutics. 2014; 4: 732–737.